Global Airway Stent Market Size, Share, Opportunities And Trends By Material Type (Metal, Silicone, Hybrid), By End User (Hospitals and Clinics, Ambulatory Surgical Centres), And By Geography - Forecasts From 2025 To 2030

  • Published : Jun 2025
  • Report Code : KSI061612095
  • Pages : 148
excel pdf power-point

Airway Stent Market Size:

The global airway stent market is expected to grow from US$141.017 million in 2025 to US$181.331 million in 2030, at a CAGR of 5.16%.

Recently, various endoscopic techniques have been developed to manage benign and malignant lesions involving the central airway: mechanical debridement, laser resection and vaporization, photodynamic therapy, and endobronchial brachytherapy. The market is expected to show significant growth during the forecast period. The growth may be attributed to the rising prevalence of several respiratory chronic disorders such as lung cancer, tuberculosis, and COPD due to rising pollution levels and the high prevalence of tobacco smoking. Increasing preference for minimally invasive procedures for treatment is also boosting the growth of the airway stent market. The development of biodegradable and drug-eluting lung stents will also boost the adoption of airway stents, thus augmenting the market growth. However, complications associated with stent implementation remain a challenge.

This research study examines the global airway stent market based on various segments: material type, end-user, and geography. First, a brief market overview details key driving factors and challenges. Next, Porter's five forces model analyzes the airway stent industry comprehensively. This is followed by industry value chain analysis which determines the companies which are part of the different processes and contributing to various sectors.

The study also presents in-depth information concerning the development, trends, and industry policies and regulations affecting the global airway stent market. Moreover, the research study analyzes the overall regulatory framework of the airway stent sector, offering stakeholders a better understanding of the key factors influencing the overall market environment.

Global Airway Stent Market – Forecasts from 2025 to 2030 are a comprehensive and latest report. It provides vital market information to executives and interested stakeholders to enable them to get vital market information. The report also analyzes the competitive landscape, details the strategies of key market players, and plots them on our vendor matrix in four quadrants: leader, follower, challenger, and niche.

The scope and coverage of the global airway stent market report are as below:

  • Global airway stent market data tables and charts
  • Market outlook with sections on drivers, restraints, Porter's, and industry value chain analysis
  • Market assessment by material type into metal, silicone, and hybrid.
  • Detailed market trends, analysis, and graphical representation by end-user into hospitals and clinics, and ambulatory surgical centers.
  • A 360o view of the demand for global airway stent market solutions/services across different geographies (North America, South America, Europe, Middle East and Africa, and Asia Pacific) with further breakdown for key countries within those regions.

Different segments covered under the global airway stent market report are as below:

  • By Material Type
    • Metal
    • Silicone
    • Hybrid
  • By End-User
    • Hospitals and Clinics
    • Ambulatory Surgical Centers
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • United Kingdom
      • Germany
      • France
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Israel
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Indonesia
      • Thailand
      • Others

Frequently Asked Questions (FAQs)

The airway stent market is expected to reach a total market size of US$181.331 million by 2030.

Airway Stent Market is valued at US$141.017 million in 2025.

The airway stent market is expected to grow at a CAGR of 5.16% during the forecast period.

The North American region is anticipated to hold a significant share of the airway stent market.

The airway stent market growth is attributed to the rising prevalence of several respiratory chronic disorders such as lung cancer, tuberculosis, and COPD due to rising pollution levels and the high prevalence of tobacco smoking.

1.  INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. GLOBAL AIRWAY STENT MARKET, BY MATERIAL TYPE

5.1. Introduction

5.2. Metal 

5.3. Silicone

5.4. Hybrid

6. GLOBAL AIRWAY STENT MARKET, BY END-USER

6.1. Introduction

6.2. Hospitals and Clinics

6.3. Ambulatory Surgical Centers

7. GLOBAL AIRWAY STENT MARKET, BY GEOGRAPHY

7.1. Introduction

7.2. North America

7.2.1. United States

7.2.2. Canada

7.2.3. Mexico

7.3. South America

7.3.1. Brazil

7.3.2. Argentina

7.3.3. Others

7.4. Europe

7.4.1. United Kingdom

7.4.2. Germany

7.4.3. France

7.4.4. Spain

7.4.5. Others

7.5. Middle East and Africa

7.5.1. Saudi Arabia

7.5.2. UAE

7.5.3. Israel

7.5.4. Others

7.6. Asia Pacific

7.6.1. Japan

7.6.2. China

7.6.3. India

7.6.4. South Korea

7.6.5. Indonesia

7.6.6. Thailand

7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

8.1. Major Players and Strategy Analysis

8.2. Emerging Players and Market Lucrativeness

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Vendor Competitiveness Matrix

9. COMPANY PROFILES

9.1. Boston Scientific Corporation

9.2. Novatech SA

9.3. ELLACS

9.4. Cook Medical

9.5. MICRO-TECH Europe GmbH

9.6. Medtronic

Boston Scientific Corporation

Novatech SA

ELLACS

Cook Medical

MICRO-TECH Europe GmbH

Medtronic